Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK7 | P49862 | 7/20 | 0.42 |
| ▸ | KLK5 | Q9Y337 | 6/20 | 0.42 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 4/20 | 0.34 |
| ▸ | PPID | Q08752 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5232415 | 0.85 | KLK7 (0.47) | KLK7KLK5SYKPPARATSHR | |
| SCHEMBL9146864 | 0.79 | CYP1A2 (0.36) | TSHRCTSL | |
| SCHEMBL4671087 | 0.78 | CYP1A2 (0.35) | CTSL | |
| SCHEMBL5234267 | 0.77 | ITGA4 (0.33) | EPHX2CTSL | |
| SCHEMBL5235644 | 0.76 | SYK (0.41) | KLK7KLK5SYKPPARATSHR | |
| SCHEMBL296601 | 0.75 | SYK (0.43) | KLK7KLK5SYKPPARAEPHX2 | |
| SCHEMBL15306512 | 0.75 | SYK (0.43) | KLK7KLK5SYKPPARAEPHX2 | |
| SCHEMBL14416216 | 0.71 | KMT2A (0.43) | KLK7KLK5SYKPPARAEPHX2 | |
| SCHEMBL5237487 | 0.71 | KMT2A (0.43) | KLK7KLK5SYKPPARAEPHX2 | |
| SCHEMBL17691231 | 0.70 | EPHX2 (0.42) | KLK7KLK5SYKPPARAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0990654-B1 | SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-6448266-B1 | COMPOUNDS SUCH AS 2-AMINO-7-(3-(3-AMINO-1-FLUOROCYCLOBUTAN-3-YL)PYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUORO-1-CYCLOPROPYL)-8-METHYL-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS, PNEUMOCOCCUS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-0990654-A1 | SUBSTITUTED CYCLOBUTYLAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2000-04-05 | — | — | EP | disclosed |